Intravenous administration of kisspeptin increases LH and testosterone concentrations in men with type 2 diabetes and HH [13], thus suggesting that the hypothalamic-pituitary-gonadal axis is intact per se in men with HH and type 2 diabetes. This evidence concerns the gene PLOD1 and type 2 diabetes mellitus.